Competitive collaboration in the pharmaceutical and biotechnology industry

2009 ◽  
Vol 14 (23-24) ◽  
pp. 1079-1081 ◽  
Author(s):  
Alph Bingham ◽  
Sean Ekins
Keyword(s):  
Biotechnology Industry

Vulnerable Company’s Triumphs in M&A Negotiation under the Impact of COVID-19 — An Empirical Study of Asian Companies

2021 ◽  
pp. 2150012
Author(s):  
Tsai-Hsin Cheng ◽  
Chung-Jian Huang ◽  
Chao-Hsien Sung ◽  
Yi-Chang Huang
Keyword(s):  
Game Theory ◽  
Empirical Study ◽  
Mergers And Acquisitions ◽  
Strategic Alliances ◽  
Information Economics ◽  
Biotechnology Industry ◽  
Equilibrium Price ◽  
Cold Chain ◽  
Investment Valuation ◽  
The Impact

The worldwide lockdown caused by COVID-19 has led to the complete suspension of shipping, land transportation, and aviation. As a result of the redistribution of global resources, governments have recently advocated acquisitions and mergers with strategic alliances and vertical integrations to revitalize the economy. This study aims to investigate how the mergers and acquisitions (M&A) were negotiated and how the equilibrium price was achieved with game theory and information economics in agricultural and fishery biotechnology industry. The findings in the present study propose that by adopting investment valuation (asset-based approach, revenue method, market method) and presenting three patents (globally unique nondrug-denatured pure male tilapia and GPS [Formula: see text]C cloud cold chain logistics), the more the vulnerable company is able to attain a triumphant price during the negotiation of M&A.

Sign in / Sign up

Export Citation Format

Share Document